|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
FY2020
12 months to Dec 31, 2020
|
FY2019
12 months to Dec 31, 2019
|
|
|---|---|---|---|---|
| Revenue | ||||
| Operating expenses: | ||||
| Cost of revenue | ||||
| Sales and marketing | ||||
| General and administrative | ||||
| Research and development( | ||||
| Depreciation and amortization | ||||
| Contingent acquisition consideration | ||||
| Restructuring and other | ||||
| Operating income | ||||
| Other income (expense): | ||||
| Other income (expense), net | ||||
| Net income before income taxes | ||||
| Income tax expense | ||||
| Net income | ||||
| Less: Net income attributable to the noncontrolling interest | ||||
| Net income attributable to SciPlay | ||||
| Basic and diluted net income attributable to SciPlay per share | ||||
| Basic (in dollars per share) | ||||
| Diluted (in dollars per share) | ||||
| Weighted average number of shares of Class A common stock used in per share calculation: | ||||
| Basic shares (in shares) | ||||
| Diluted shares (in shares) |
Loading...
